Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Phase 1 Recruiting
21 enrolled
A Study of PHN-012 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
165 enrolled
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
76 enrolled
A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
Phase 1 Recruiting
36 enrolled
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Phase 1 Recruiting
145 enrolled
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Phase 1 Recruiting
694 enrolled
Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer
Phase 1 Recruiting
18 enrolled
CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
Phase 1 Recruiting
43 enrolled
Testing the Addition of Sunitinib Malate to Lutetium Lu 177 Dotatate (Lutathera) in Pancreatic Neuroendocrine Tumors
Phase 1 Recruiting
24 enrolled
Gemcitabine and Leflunomide in Patients With Advanced Unresectable Pancreatic Cancer
Phase 1 Recruiting
19 enrolled
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Phase 1 Recruiting
100 enrolled
Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors
Phase 1 Recruiting
116 enrolled
Perioperative Fostamatinib With Gemcitabine and Nab-paclitaxel in Resectable Pancreatic Cancer
Phase 1 Recruiting
36 enrolled
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 Recruiting
310 enrolled
PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 1 Recruiting
26 enrolled
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
Phase 1 Recruiting
188 enrolled
MTAPESTRY 103
Phase 1 Recruiting
350 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
CHANCES
Phase 1 Recruiting
27 enrolled
Autologous CAR-T Cells Targeting B7-H3 in PDAC
Phase 1 Recruiting
27 enrolled
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
Phase 1 Recruiting
134 enrolled
A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer
Phase 1 Recruiting
12 enrolled
TR-002 for the Treatment of Advanced, Unresectable or Metastatic Solid Tumors and Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
Phase 1 Recruiting
52 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
CAR-NK Cells (CL-NK-003) in Pancreatic Cancer
Phase 1 Recruiting
9 enrolled
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Phase 1 Recruiting
51 enrolled
Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma
Phase 1 Recruiting
100 enrolled
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Phase 1 Recruiting
405 enrolled
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
80 enrolled
A Study of MGC026 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
250 enrolled
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Phase 1 Recruiting
574 enrolled
FTT PET/CT in Pancreatic Neuroendocrine Tumors
Phase 1 Recruiting
12 enrolled
SHARON
Phase 1 Recruiting
24 enrolled
Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors
Phase 1 Recruiting
18 enrolled
A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
Phase 1 Recruiting
495 enrolled
IX001 TCR-T
Phase 1 Recruiting
9 enrolled
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
Phase 1 Recruiting
195 enrolled
Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy
Phase 1 Recruiting
20 enrolled
KRAS-Targeted Vaccine Combined With Balstilimab and Botensilimab for Patients With Stage IV MMR-p Colorectal Cancer and Pancreatic Ductal Cancer
Phase 1 Recruiting
54 enrolled
A Study of DEG6498 in Participants With Solid Tumors
Phase 1 Recruiting
100 enrolled
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
Phase 1 Recruiting
336 enrolled
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancer
Phase 1 Recruiting
37 enrolled
EUS RFA for Treatment of Pancreatic Ductal Adenocarcinoma (PDAC)
Phase 1 Recruiting
15 enrolled
Chemotherapy and Irreversible Electroporation in the Treatment of Advanced Pancreatic Adenocarcinoma
Phase 1 Recruiting
20 enrolled
CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors
Phase 1 Recruiting
108 enrolled
A Study of BL-B01D1 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumor and Other Solid Tumor
Phase 1 Recruiting
96 enrolled
AOH1996 for the Treatment of Refractory Solid Tumors
Phase 1 Recruiting
92 enrolled
A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Lower Expression Gastrointestinal Cancer and Other Solid Tumors
Phase 1 Recruiting
20 enrolled
A Phase 1 Trial of ERX-315 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
15 enrolled
A Study of MGC028 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
124 enrolled